Black Diamond Therapeutics, Inc.

NASDAQ:BDTX

Biotechnology

Healthcare
$1.43 -2.40%

-$0.04 today

Market cap
$82.18M
Beta
3.23
P/E (TTM)
-2.2
EPS (TTM)
-$0.75
52W Low $1.62High $4.94

Volume 0.60M

Average 1.31M

BDTX Income Before Tax

Profit after all operating and non-operating items but before income tax.

Black Diamond Therapeutics, Inc.NASDAQ: BDTX

Income Before Tax · Q1 FY2026 · quarter ended Mar 2026

Income before tax turns negative

Q1 FY2026 income before tax was -$9.04M, compared with $56.54M a year earlier. Trailing-twelve-month income before tax was -$43.21M.

Context

  • Income before tax amounted to 32.0% of revenue in FY2025.
  • Income before tax increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly income before tax holds near -$9.04M or moves back toward the trailing-twelve-month quarterly average of -$10.8M.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
-$9.04M+40.2% QoQ
Last fiscal yearDec 2025
$22.37M+132.1% YoY
LTMMar 2026
-$43.21M-948.8% YoY
Income Before Tax past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-116.0%——
1 year+132.1%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Income Before Tax history

USD · from the income statement

Latest · FY2025
22.37M USD
Year-over-year change
+132.1%

Income Before Tax vs competitors

How BDTX compares with its peers on the latest reported figures

  • Peers report in different currencies, so income before tax is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -948.8% is the lowest of 11, against a peer median of +10.7%.
BDTX Competitors
Income Before Tax for BDTX and competitors
Company Period LTM YoY 3-year CAGR% of revenue
ABEOAbeona Therapeutics Inc.LTM Mar 2026$66.24M USD+249.9%—455.6%
FENCFennec Pharmaceuticals Inc.LTM Mar 2026-$8.27M USD+41.2%—16.2%
BDTXBlack Diamond Therapeutics, Inc.LTM Mar 2026-$43.21M USD-948.8%——
IMRXImmuneering CorporationLTM Mar 2026-$54.44M USD+11.9%——
ENTAEnanta Pharmaceuticals, Inc.LTM Mar 2026-$61.89M USD+37.4%—89.4%
AARDAardvark Therapeutics, Inc. Common StockLTM Mar 2026-$69.87M USD-152.1%——
FHTXFoghorn Therapeutics Inc.LTM Mar 2026-$75.32M USD+6.4%—266.9%
TNYATenaya Therapeutics, Inc.LTM Mar 2026-$83.01M USD+21.5%—36891.1%
AVTXAvalo Therapeutics, Inc.LTM Mar 2026-$84.57M USD-215.6%—143340.7%
CRBUCaribou Biosciences, Inc.LTM Mar 2026-$133.77M USD+9.5%—1194.0%
IVAInventiva S.A.FY2025-€342.33M EUR-86.1%—7636.1%
Peer median (excluding BDTX) —+10.7%—824.8%

Competitors are the stored peer set for BDTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue000070M
Cost of Revenue00437K0325K
Gross Profit00(437K)069.68M
Gross Margin————99.5%
Research & Development96.83M64.44M58.91M51.31M33.56M
Selling, General & Admin30.04M28.39M27.11M27.47M16.57M
Operating Expenses126.87M92.83M86.02M78.78M49.81M
Depreciation & Amortization205K508K437K343K325K
EBITDA(125.39M)(90.66M)(82.01M)(69.33M)22.69M
EBITDA Margin————32.4%
Operating Income(126.87M)(92.83M)(86.46M)(78.78M)19.87M
Operating Margin————28.4%
Interest Income3.46M2.03M1.92M2.18M4.06M
Interest Expense00000
Other Income / Expenses1.28M1.66M4.02M9.11M2.5M
Income Before Tax(125.6M)(91.17M)(82.44M)(69.68M)22.37M
Pre-Tax Margin————32.0%
Income Tax Expense00000
Net Income(125.6M)(91.17M)(82.44M)(69.68M)22.37M
Net Margin————32.0%
EPS (Basic)(3.47)(2.52)(1.88)(1.27)0.39
EPS (Diluted)(3.47)(2.52)(1.88)(1.27)0.39
Weighted Avg Shares36.19M36.23M43.95M55.03M56.87M
Weighted Avg Shares (Diluted)36.19M36.23M43.95M55.03M57.56M

Black Diamond Therapeutics, Inc.

NASDAQ:BDTX

Intrinsic Alpha fair value

Locked

Current Price

$1.43

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.